The average age of the respondents was 59, 9 ± 19, 2 years (range 18 - 78 years). More than half of these respondents were over 60 years (60%). The evaluation indicates those with morbidity and those without known morbidity, the difference was statistically significant (p <0.001). It is noted that respondents with overweight and morbid risk were more numerous respectively with a rate of 38% and 31.8%. In the medical history of patients, excluding stroke patients who were in equal proportion to those without stroke (p = 0.052); the other parameters were different (p <0.05).
In the correlation analysis: the IIEF-5 score was negatively and linearly correlated with age (p <0.001), with a correlation of r = 0.856. The BMI was significantly and negatively associated with the IIEF-5 score (r = 0.0661). The waist circumference was significantly and negatively associated with IIEF-5 score despite this statistical significance, this correlation was moderately strong (r = 0.596). In the multiple linear correlation: The age of the respondents and the BMI had emerged as the major linear and negative determinant of the IIEF-5 score; these variables can directly explain 66% of its variability (R 2 = 0.663).
In bivariate analysis of the morphological characteristics of the respondents, we did not note a risk of erectile dysfunction with these variables (p> 0.05). The frequency of erectile dysfunction increased regardless of the type of dysfunction recorded, with increasing age.
In bivariate analysis comparing age group of erectile dysfunctions, the incidence of erectile dysfunction was 67, 3% in the age group of 40-60 years old, 94, 8% in the age group > 60 years. It was 40, 4% in the group age<40 years. The risk of erectile dysfunction was 3- and 6- times higher in the age group> 40 years compared with the young age group p < 40 years (p <0.05).
In other bivariate analysis, the frequency of erectile dysfunction was 87.5% in diabetics compared to 74.9% in non-diabetics (0.025), conferring a risk 2 times higher erectile dysfunction in diabetics than non-diabetics. The frequency of this disorder in hypertensive patients and those with stroke was 92.3% and 86%, respectively, compared with those who did not have hypertension (p <0.001) and stroke (p = 0.002) with risk evaluated in these two groups of 5 and 3 times respectively. On the other hand, taking stimulants gave respondents a 3-fold protection compared to those who did not take stimulants (p = 0.007). The analysis of factors Associated with Erectile Dysfunction, in univariate analysis of logistic regression, age between 40-60 years,> 60 years, diabetes mellitus, hypertension, stroke, and stimulant intake had emerged as determinants of erectile dysfunction in the general population study. After adjustment for all these variables, age> 60 years [OR: 9.87, 95% CI: 6.42-10.48), p <0.001), diabetes mellitus [OR: 2.99, 95% CI: 1.80-4.95), p = 0.013) and stroke [OR: 2.1, 95% CI: 1.36-3.39, p = 0.012] were the independent risk factors associated with erectile dysfunction in the study population.